Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HempFusion Wellness, formerly known as CBD Med Research Corp, is a health and wellness company specializing in the development and distribution of hemp-derived cannabidiol (CBD) products. The company utilized a proprietary "Whole Food Hemp Complex" to produce a variety of delivery forms, including tinctures, capsules, and topicals, aimed at addressing consumer needs for stress relief, sleep support, and pain management. Its brand portfolio included HempFusion, Sagely Naturals, and Apothecanna, which were distributed through thousands of retail locations across the United States. The company distinguished itself through a focus on regulatory compliance and clinical research, including participation in large-scale safety studies. Formerly listed on the TSX and OTCQX, the company faced financial challenges and filed for bankruptcy protection in 2023, after which its assets were acquired by BZAM Ltd.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Med Research Corp.